Does Insurance Cover Weight Loss Medication in Billings, MT? An Expert Guide

Insurance coverage for weight loss medication in Billings, MT, is one of the most common questions patients have before starting treatment with GLP-1 drugs like semaglutide or tirzepatide. This article explains how Montana Medicaid, Medicare, and private plans currently approach medication in Billings, MT, so you can go into your first appointment prepared.

Does Montana Medicaid Cover Weight Loss Medication?

Montana Medicaid currently has limited coverage for GLP-1 medications used specifically for obesity. Montana Medicaid covers GLP-1 medications for diabetes with prior authorization; obesity coverage is limited under the current benefit structure. In plain terms, if your provider prescribes semaglutide (Wegovy) or tirzepatide (Zepbound) purely for weight loss, Medicaid may not cover it right now.

Coverage of GLP-1 drugs for the treatment of obesity remains optional for states, while coverage is required for drugs approved for the treatment of diabetes and, since March 2024, for the treatment of cardiovascular disease. This means Montana is not alone, and the rules can shift at any time.

What Diagnosis Is Needed for Coverage?

A confirmed diagnosis of type 2 diabetes is the most likely path to GLP-1 coverage through Montana Medicaid today. Even with coverage, prior authorization is typically required, with criteria such as a BMI of 30 or higher, or 27 or higher with documented comorbidities and documented diet and exercise failures. Your provider will need to submit supporting clinical documentation for any prior authorization request.

What About Private Insurance and Medicare?

Private insurer coverage for weight loss medication varies widely: 25 to 40 percent of commercial plans cover GLP-1s specifically for weight loss, while 80 to 90 percent cover them for diabetes. Billings residents with employer-sponsored plans through large insurers like BCBS or PacificSource should call their member services line directly to confirm their specific formulary.

Medicare has historically excluded weight-loss-only prescriptions. Starting July 2026, the Medicare GLP-1 Bridge program is expected to cover Wegovy and Zepbound for eligible beneficiaries nationwide, including Montana, with an expected copay of $50 per month for patients with a BMI of 35 or higher, or 27 or higher with qualifying conditions.

What If My Plan Denies the Claim?

A denial is not necessarily the end of the road. You may have options:

• Appeal the decision with a letter of medical necessity from your provider.
• Ask your provider about manufacturer savings programs. Wegovy and Zepbound offer savings cards for eligible patients, which can significantly reduce monthly out-of-pocket costs.
• Ask your provider about patient assistance programs for lower-income households.

Self-Pay Cost Ranges in Billings, MT

Patients paying out of pocket should plan for real costs. These medications, which are intended for long-term use, can cost over $1,000 per month without insurance. With coverage, copays typically range from $25 to $100 per month. Discussing self-pay options with your provider before starting treatment helps avoid surprises.



Take the Next Step Toward Medically Supervised Weight Loss

A conversation with a licensed provider is the fastest way to understand your coverage. Fuller Family Medicine offers weight loss medication and injections, including semaglutide and tirzepatide, with medical oversight at every step. Contact the office to schedule a consultation, or call (406) 651-9355 today. You can also find us on Google Maps at Fuller Family Medicine to get directions or read patient reviews.